Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXeros Tech Regulatory News (XSG)

Share Price Information for Xeros Tech (XSG)

Share Price is delayed by 15 minutes
Get Live Data
1.45    0.05 (3.45%)
Bid:
1.40
Ask:
1.50
Spread: 0.10 (7.143%)
Market Cap: £12.93m
XSG Live PriceLast checked at - London Stock Exchange

Intraday Xeros Tech Share Chart

Directorate Change

20 Jul 2021 07:00

RNS Number : 7166F
Xeros Technology Group plc
20 July 2021
 

Xeros Technology Group plc

 

Directorate Change

 

Xeros Technology Group plc (AIM: XSG, 'the Group', 'Xeros'), the developer and licensor of platform technologies which transform the sustainability and economics of clothing and fabrics during their lifetime, today announces that Rachel Nooney joins the Board as a non-executive director.

 

Rachel Nooney is an experienced retail marketing executive having held senior Head of Brand and Marketing roles at New Look and Marks & Spencer plc. Rachel is currently the owner and principal consultant of shoreseven, a strategic marketing consultancy.

 

 

Klaas de Boer, Chairman of Xeros, said: "Rachel's strong consumer retail brand and marketing experience and her strong focus on making the fashion industry's supply chain more sustainable will add a new perspective, strengthen the Xeros Board and help drive market adoption of Xeros' platform technologies. We very much welcome her appointment".

 

Further information:

 

Full name: Rachel Louise Nooney

Age 52

 

Rachel does not hold any ordinary shares in the Company.

 

There are no other disclosures required for the purposes paragraph (g) of Schedule 2 of the AIM Rules for Companies.

 

Enquiries

Xeros Technology Group plc

Mark Nichols, Chief Executive Officer

Paul Denney, Chief Financial Officer

Tel: 0114 321 6328

 

finnCap Limited (Nominated Advisor & Broker)

Julian Blunt / Teddy Whiley, Corporate Finance

Andrew Burdis / Sunila de Silva, ECM

Tel: 020 7220 0500

 

Notes to Editors

Xeros Technology Group plc has developed and licenses two platform technologies which transform sustainability, performance and economics in the manufacturing and laundering of garments and fabrics.

The Company's XTend™ technology platform uses XOrbs™ in conjunction with XDrums™ to significantly reduce the amount of water and chemistry used in the dyeing, finishing or laundering of garments and fabrics. XOrbs increase the efficiency of these processes which require molecules to be either affixed or removed from substrates. In the case of laundry, they are proven to significantly increase the life of clothes and fabrics. The results being major improvements in economic, operational, product and environmental outcomes.

XDrum is Xeros' low-cost machine design which enables XOrbs to be introduced into and subsequently removed from process cycles. The design provides Original Equipment Manufacturers with the ability to make simple changes to their products to incorporate the Company's XOrb technology.

The Group has signed multiple license agreements for its XDrum and XOrb technologies with leading OEMs in major commercial and domestic markets.

XFiltra™ is the Company's proprietary washing machine filtration technology platform which prevents harmful microfibres including microplastics, generated during washing cycles, from being released into the world's rivers and oceans. Microfibres released into the environment from clothing and fabrics during their laundering, being a major source of pollution in the environment and contamination in the food chain.

The Company has signed a license agreement with leading commercial laundry equipment manufacturer Girbau for the deployment of XFiltra in commercial laundries and has plans to also license its design into the domestic laundry market.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABXGDRDUBDGBC
Date   Source Headline
28th Apr 20267:00 amRNSFull Year Results 2025
21st Apr 20267:00 amRNSNotice of Results and Online Presentation
5th Mar 20267:00 amRNSPurchase Order ahead of European Launch of XF3
11th Feb 202610:39 amRNSHolding(s) in Company
2nd Feb 20267:00 amRNSBoard Change
27th Jan 20267:00 amRNSTrading Update
7th Jan 20262:52 pmRNSTR-1 First Equity
2nd Jan 202611:46 amRNSBlock listing Interim Review
11th Dec 20251:06 pmRNSTR-1 Entrepreneurs Fund
2nd Dec 20254:48 pmRNSTR-1 Lombard Odier
2nd Dec 20252:26 pmRNSTR-1 Dowgate
2nd Dec 202511:10 amRNSTR-1 Maven
28th Nov 202511:02 amRNSResults of General Meeting and Director Dealings
27th Nov 202512:28 pmRNSResult of Follow-on Subscription and TVR
26th Nov 20254:44 pmRNSTR-1 Spreadex
11th Nov 20251:14 pmRNSResult of Retail Offer
7th Nov 202510:15 amRNSResult of Fundraising
7th Nov 20257:00 amRNSRetail Offer
6th Nov 20256:32 pmRNSProposed Fundraise
24th Oct 20253:07 pmRNSBlock listing Interim Review
14th Oct 20255:11 pmRNSTR-1 Maven
10th Oct 20255:20 pmRNSTR-1 Dowgate
9th Oct 20252:05 pmRNSTR-1 Spreadex
9th Oct 202511:04 amRNSTR-1 First Equity
8th Oct 20257:00 amRNSBreakthrough Launch Agreement
1st Oct 20252:08 pmRNS-RInterim Results 2025 Online Presentation
30th Sep 20257:00 amRNSInterim Results 2025
15th Sep 20256:07 pmRNSTR-1 Dowgate
12th Sep 20251:03 pmRNSTR-1 Dowgate
5th Aug 202512:13 pmRNSTR-1 First Equity
7th Jul 20252:33 pmRNSTR-1 Spreadex
19th Jun 20251:46 pmRNSResult of AGM
5th Jun 202510:11 amRNSCorrection - Application for Block Listing
4th Jun 202510:00 amRNSApplication for Block Listing
29th May 20252:43 pmRNSTR-1 Spreadex
28th May 20253:32 pmRNSTR-1 First Equity
28th May 20252:31 pmRNSTR-1 Spreadex
27th May 20252:37 pmRNSNotice of AGM and Posting of Annual Report
20th May 20257:00 amRNSFull Year Results 2024 and Trading Update
9th May 202511:08 amRNSTR-1 Spreadex
7th May 20257:00 amRNSNotice of Results and Online Presentation
6th May 202510:10 amRNSTR-1 Maven Capital
2nd May 20254:00 pmRNSTR-1 Spreadex
1st May 20254:35 pmRNSTR-1 - First Equity
31st Mar 20257:00 amRNSGrant of Options
7th Mar 202512:56 pmRNSTR-1 Spreadex
17th Feb 20252:18 pmRNSTR-1 Spreadex
17th Feb 202511:07 amRNSTR-1 First Equity
13th Feb 202512:05 pmRNSTR-1 Spreadex
13th Feb 202510:21 amRNSTR-1 First Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.